— Know what they know.
Not Investment Advice

ERNA Institutional Ownership

Ernexa Therapeutics Inc.
1W: -14.2% 1M: -34.8% 3M: -54.0% YTD: -89.8% 1Y: -89.6% 3Y: -99.6% 5Y: -100.0%
$2.96
+0.00 (+0.00%)
 
Weekly Expected Move ±8.0%
$2 $3 $3 $3 $3
NASDAQ · Healthcare · Biotechnology · Tech Score Strong Sell · Power 23 · $4.8M mcap · 1M float · 30.47% daily turnover · Short 55% of daily vol

Institutional Ownership — ERNA

10
Institutional Holders
+0 vs prior quarter
0.0%
Ownership
+0.00pp
$0M
Total Invested
10
New Positions
0
Increased
0
Reduced
0
Closed
0.00
Put/Call Ratio

Top Institutional Holders (10 total)

# Holder Shares Value Change Change % Holding Period Filing
1 CITADEL ADVISORS LLC NEW 15,104 $$45K — +0.0% 1Q SEC ↗
2 VANGUARD FIDUCIARY TRUST CO NEW 8,336 $$25K — +0.0% 1Q SEC ↗
3 Dauntless Investment Group, LLC NEW 6,000 $$18K — +0.0% 1Q SEC ↗
4 VANGUARD CAPITAL MANAGEMENT LLC NEW 5,684 $$17K — +0.0% 1Q SEC ↗
5 Tradewinds Capital Management, LLC NEW 361 $$1K — +0.0% 1Q SEC ↗
6 BlackRock, Inc. NEW 33 $$0K — +0.0% 1Q SEC ↗
7 ASSETMARK, INC NEW 5 $$0K — +0.0% 1Q SEC ↗
8 BNP PARIBAS FINANCIAL MARKETS NEW 1 $$0K — +0.0% 1Q SEC ↗
9 SBI Securities Co., Ltd. NEW 1 $$0K — +0.0% 1Q SEC ↗
10 Steward Partners Investment Advisory, NEW 0 $$0K — — 1Q SEC ↗

Recent Activity

Sold Out (0)

No sold-out positions this quarter.

Biggest Increases (0)

None.

Biggest Decreases (0)

None.

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms